Inogen, Inc. Overview Investor Presentation November 2, 2022 Notice Regarding Forward-Looking Statements 1 This presentation and the accompanying oral presentation (the "Presentation") include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on current expectations, estimates and projections based on information currently available to management. These forward-looking statements include, among others, statements relating to our business s ...

Inogen, Inc. (NASDAQ:INGN) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Caltrider - CFO Conference Call Participants Brett Fishbin - KeyBanc Maggie Boeye - William Blair Rohin Patel - JPMorgan Mike Matson - Needham & Company Operator Welcome to the Inogen's Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) Delaware 33-0989359 (State or other jurisdiction of in ...

Inogen, Inc. (NASDAQ:INGN) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Jason Somer - General Counsel Nabil Shabshab - President & CEO Kristin Caltrider - CFO Conference Call Participants Lilia-Celine Lozada - J.P. Morgan Matthew Mishan - KeyBanc Capital Markets Mike Matson - Needham & Company Operator Welcome to Inogen's First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) Delaware 33-0989359 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Goleta, CA 93117 (Address of principal executive offices) (Zi ...

Inogen, Inc. Overview Investor Presentation February 24, 2022 Notice Regarding Forward-Looking Statements 1 These slides and the accompanying oral presentation (the "Presentation") include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on current expectations, estimates and projections based on information currently available to management. These forward- looking statements include, among others, statements relating to our business stra ...

Inogen, Inc. (NASDAQ:INGN) Q4 2021 Earnings Conference Call February 24, 2022 5:00 PM ET Company Participants Jason Somer - General Counsel Nabil Shabshab - Chief Executive Officer Mike Sergesketter - Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Brett Fishbin - KeyBanc Maggie Boeye - William Blair Mathew Blackman - Stifel Operator Welcome to Inogen's 2021 Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following man ...

INOGEN, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 Address of principal executive offices Zip Code I.R.S. Employer Identification No. (Exact name of registrant as specified in ...

Inogen, Inc. (NASDAQ:INGN) Q3 2021 Earnings Conference Call November 4, 2021 5:00 PM ET Company Participants Jason Somer - General Counsel Nabil Shabshab - CEO Alison Bauerlein - CFO Conference Call Participants Robert Marcus - JPMorgan Margarate Boeye - William Blair Danielle Antalffy - SVB Leerink Michael Matson - Needham & Company Matthew Mishan - KeyBanc Mathew Blackman - Stifel Operator Greetings, and welcome to Inogen's Third Quarter 2021 Earnings Release Conference Call. [Operator Instructions] As a ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) Delaware 33-0989359 (State or other jurisdiction ...